{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:16:05Z","timestamp":1707524165028},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,4]]},"DOI":"10.7759\/cureus.13127","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T14:38:05Z","timestamp":1612449485000},"source":"Crossref","is-referenced-by-count":0,"title":["Diuretic-Resistant Ascites Following Laparoscopic Surgery in a Patient With Chronic Myeloid Leukemia on Imatinib Therapy"],"prefix":"10.7759","author":[{"given":"Efthymia","family":"Pappa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Gkeka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ifigeneia","family":"Kiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pagona","family":"Gourna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantinos","family":"Christopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.11.143","article-title":"Practical management of patients with chronic myeloid leukemia receiving imatinib","volume":"21","author":"Deininger MWN","year":"2003","unstructured":"Deininger MWN, O\u2019Brien SG, Ford JM, Druker BJ. Practical management of patients with chronic myeloid leukemia receiving imatinib. J Clin Oncol. 2003, 21:1637-1647. 10.1200\/JCO.2003.11.143","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.9-3-271","article-title":"Indications for imatinib mesylate therapy and clinical management","volume":"9","author":"Guilhot F","year":"2004","unstructured":"Guilhot F. Indications for imatinib mesylate therapy and clinical management. Oncologist. 2004, 9:271-281. 10.1634\/theoncologist.9-3-271","journal-title":"Oncologist"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.111","article-title":"Class effects of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia","volume":"23","author":"Giles FJ","year":"2009","unstructured":"Giles FJ, M O\u2019Dwyer M, Swords R. Class effects of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia. Leukemia. 2009, 23:1698-1707. 10.1038\/leu.2009.111","journal-title":"Leukemia"},{"key":"ref4","article-title":"Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors","volume":"61","author":"Pietras K","year":"2001","unstructured":"Pietras K, \u00d6stman A, Sj\u00f6quist M, Buchdunger E, Reed RK, Heldin CH, Rubin K. Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res. 2001, 61:2929-2934.","journal-title":"Cancer Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1996.sp021584","article-title":"A novel physiological function for platelet-derived growth factor-BB in rat dermis","volume":"495","author":"Rodt S\u00c5","year":"1996","unstructured":"Rodt S\u00c5, \u00c5hl\u00e9n K, Berg A, Rubin K, Reed RK. A novel physiological function for platelet-derived growth factor-BB in rat dermis. J Physiol. 1996, 495:193-200. 10.1113\/jphysiol.1996.sp021584","journal-title":"J Physiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2006.18.1.56","article-title":"Modulation of vascular endothelium by imatinib: a study on the EA.hy 926 endothelial cell line","volume":"18","author":"Vrekoussis T","year":"2006","unstructured":"Vrekoussis T, Stathopoulos EN, De Giorgi U, et al.. Modulation of vascular endothelium by imatinib: a study on the EA.hy 926 endothelial cell line. J Chemother. 2006, 18:56-65. 10.1179\/joc.2006.18.1.56","journal-title":"J Chemother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew245","article-title":"Fulminant capillary leak syndrome in a patient with systemic sclerosis treated with imatinib mesylate","volume":"55","author":"Hinchcliff ME","year":"2016","unstructured":"Hinchcliff ME, Lomasney J, Johnson JA, Varga J. Fulminant capillary leak syndrome in a patient with systemic sclerosis treated with imatinib mesylate. Rheumatology (Oxford). 2016, 55:1916-1918. 10.1093\/rheumatology\/kew245","journal-title":"Rheumatology (Oxford)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22757","article-title":"A prospective analysis of imatinib-induced c-KIT modulation in ovarian cancer: a phase II clinical study with proteomic profiling","volume":"110","author":"Posadas EM","year":"2007","unstructured":"Posadas EM, Kwitkowski V, Kotz HL, et al.. A prospective analysis of imatinib-induced c-KIT modulation in ovarian cancer: a phase II clinical study with proteomic profiling. Cancer. 2007, 110:309-314. 10.1002\/cncr.22757","journal-title":"Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12893-016-0123-8","article-title":"Inflammatory reaction to fish oil coated polypropylene mesh used for laparoscopic incisional hernia repair: a case report","volume":"16","author":"Kong CY","year":"2016","unstructured":"Kong CY, Lai LL, Khoo AY, Rahman NA, Chin KF. Inflammatory reaction to fish oil coated polypropylene mesh used for laparoscopic incisional hernia repair: a case report. BMC Surg. 2016, 16:8. 10.1186\/s12893-016-0123-8","journal-title":"BMC Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.75.5.942","article-title":"The anti-inflammatory agent alpha-trinositol exerts its edema-preventing effects through modulation of beta 1 integrin function","volume":"75","author":"Rodt S\u00c5","year":"1994","unstructured":"Rodt S\u00c5, Reed RK, Ljungstr\u00f6m M, Gustafsson TO, Rubin K. The anti-inflammatory agent alpha-trinositol exerts its edema-preventing effects through modulation of beta 1 integrin function. Circ Res. 1994, 75:942-948. 10.1161\/01.res.75.5.942","journal-title":"Circ Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000207393.67851.d4","article-title":"Platelet-derived growth factor BB-mediated normalization of dermal interstitial fluid pressure after mast cell degranulation depends on \u03b23 but not \u03b21 integrins","volume":"98","author":"Lid\u00e9n \u00c5","year":"2006","unstructured":"Lid\u00e9n \u00c5, Berg A, Nedreb\u00f8 T, Reed RK, Robin K. Platelet-derived growth factor BB-mediated normalization of dermal interstitial fluid pressure after mast cell degranulation depends on \u03b23 but not \u03b21 integrins. Circ Res. 2006, 98:635-641. 10.1161\/01.RES.0000207393.67851.d4","journal-title":"Circ Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/50097-diuretic-resistant-ascites-following-laparoscopic-surgery-in-a-patient-with-chronic-myeloid-leukemia-on-imatinib-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:30Z","timestamp":1707507210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/50097-diuretic-resistant-ascites-following-laparoscopic-surgery-in-a-patient-with-chronic-myeloid-leukemia-on-imatinib-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,4]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.13127","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,4]]}}}